Structure via PubChem · Public domain (PubChem)
caspofungin
Sign in to saveAlso known as MK-991, 1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N(2)-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R)-3-hydroxy-L-ornithine]-pneumocandin b0, (4R,5S)-5-((2-Aminoethyl)amino)-N(2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(P-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide, L-743872
Caspofungin (INN; brand name Cancidas) is a lipopeptide antifungal drug from Merck & Co., Inc. It is a member of a class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.image
- Caspofungin.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 275
- Drug.tradename
- Cancidas
- Drug.MedlinePlus
- a615001
- Drug.DailyMedID
- Caspofungin
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- Intravenous
- Drug.ATC_prefix
- J02
- Drug.ATC_suffix
- AX04
- Drug.legal_AU
- S4
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.legal_status
- Rx-only
- Drug.bioavailability
- 100% (intravenous use only)
- Drug.protein_bound
- ~97%
via Wikipedia infobox
Chemical data
- Formula
- C52H88N10O15
- Molecular weight
- 1093.3 g/mol
- IUPAC name
- N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
- SMILES
- CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O
- InChIKey
- JYIKNQVWKBUSNH-OGZDCFRISA-N
- XLogP
- 0.3
- Polar surface area
- 412 Ų
- H-bond donors
- 16
- H-bond acceptors
- 18
- Formal charge
- 0
via PubChem
Research
4,117 papers- Caspofungin.Indian pediatrics · 2008
- Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
- Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
- Rezafungin vs caspofungin for the treatment of invasive candidiasis: A systematic review and meta-analysis.Diagnostic microbiology and infectious disease · 2025
- Caspofungin: a review of its characteristics, activity, and use in intensive care units.Expert review of anti-infective therapy · 2020
via PubMed
Wikidata facts
- Mass
- 1092.643062
Show 6 more facts
- chemical formula
- C₅₂H₈₈N₁₀O₁₅
- canonical SMILES
- CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O
- isomeric SMILES
- CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O
- defined daily dose
- 50
- NCI Thesaurus ID
- C28910
- Commons category
- Caspofungin
Sources (3)
via Wikidata · CC0
~10 min read
Article
10 sectionsContents
- Medical uses
- Spectrum of activity
- Specific populations
- Adverse effects
- Liver effects
- Sensitivity reactions
- Pharmacology
- Pharmacokinetics
- Interactions
- References
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = | image = Caspofungin.svg | image_class = skin-invert-image | width = 275 | alt = | pronounce = | tradename = Cancidas | Drugs.com = | MedlinePlus = a615001 | DailyMedID = Caspofungin | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Intravenous | class = | ATC_prefix = J02 | ATC_suffix = AX04 | ATC_supplemental = | legal_AU = S4 | legal_AU_comment = | legal_BR = | legal_BR_comment = | legal_CA = | legal_CA_comment = | legal_DE = | legal_DE_comment = | legal_NZ = | legal_NZ_comment = | legal_UK = | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | legal_UN = | legal_UN_comment = | legal_status = Rx-only
| bioavailability = 100% (intravenous use only) | protein_bound = ~97% | metabolism = Peptide hydrolysis, N-acetylation | metabolites = | onset = | elimination_half-life = 9–11 hours | duration_of_action = | excretion = Kidney (41%), feces (35%)